Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesJan 15, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 11, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 10, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 9, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 2, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 28, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 27, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 20, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 20, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 18, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesDec 14, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 16, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 5, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 2, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 1, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 26, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 5, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 5, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 28, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 27, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 18, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 17, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 17, 2018View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesSep 7, 2018View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 6, 2018View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information